摘要
依据SFDA《药品临床试验管理规范》 ,ICHGCP ,WHOGCP ,以及我院临床试验的实践 ,制订临床试验机构研究者的标准操作规程 ,包括研究者资格与条件 ,试验前的准备 ,受试者的招募和筛选 ,受试者的知情同意 ,方案的依从性 ,受试者的医疗 ,随机化程序和破盲 ,安全性报告 ,源文件和源数据 ,病例报告表 ,试验用药的管理 ,试验的终止或暂停 ,进展报告和总结报告 ,档案等。
Standard Operating Procedures (SOP) of clinical investigators are established according to SFDA, ICH and WHO Good Clinical Practice standards, and experiences of clinical trials practice in our hospital. It includes qualification and competence of investigators, prior to initiation of the study, screening and recruitment of study subjects, obtain informed consent from all trial subjects, protocol compliance, provide medical care for trial subjects, randomization procedures and unblinding, safety reporting, source data/document, case report forms, product management, premature termination or suspension of a trial, progress and final reports, and investigator’s files.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2004年第8期954-957,共4页
Chinese Journal of Clinical Pharmacology and Therapeutics
基金
国家科学技术部"临床试验关键技术及平台研究"课题资助(№ 2 0 0 2AA2Z3 41i)
关键词
临床试验机构
研究者
标准操作规程
源文件
病例报告表
institution of clinical trial
investigator
Standard Operating Procedures(SOP)
source document
case report forms